Dallas-headquartered clinical stage biopharmaceutical firm Lantern Pharma has shared positive results from its ongoing clinical trial on a new treatment for patients diagnosed with pancreatic cancer.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,